Topical Pain Relief Market Size, Share & Trends Analysis Report By Drug Class (Opioids, Non-opioids), By Formulation (Creams and Ointments, Gels, Sprays, Patch, Others), By Type (Prescription Based, Over-the-counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Market Overview

The global topical pain relief market size was valued at USD 11.15 Billion in 2023. It is estimated to reach USD 19.09 Billion by 2032, growing at a CAGR of 5.90% during the forecast period (2024–2032).

The topical pain relief market involves the development, manufacture and distribution of medicated products that are applied directly to the skin to relieve pain and discomfort. These medications target localized muscle, joint, and nerve pain and offer a non-invasive and often safer alternative to oral pain relievers. There is a wide variety of formulations in the market, including creams, gels, sprays and patches, each tailored to specific needs and preferences. The market's focus on convenience, non-invasive use and its adaptation to the growing need for safer pain relief allows for significant expansion.

The topical pain relief market is fuelled by several factors: an aging population with an increase in chronic pain problems such as arthritis, awareness of opioid risks leading to a search for safer pain relief options, and increased participation in sports and outdoor activities that can lead to muscle and joint pain. This demand for convenient and non-addictive pain relief is driving the market for topical creams, gels and patches.

Market Dynamics

Global topical pain relief market drivers:

Rising prevalence of painful conditions

The rising prevalence of painful conditions like arthritis, back pain, and diabetic neuropathy is a key driver of the topical pain relief market. As these chronic conditions become more widespread, so does the demand for effective pain management solutions. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 58.5 million adults in the United States have arthritis. The CDC has projected that by 2040, approximately 35 million people will be affected by arthritis. This led to an acceleration of the market. Topical pain relievers offer a convenient and targeted approach, addressing this growing need.

Rising prevalence of painful conditions

The increased popularity of non-opioid pain medications is contributing to the growth of the topical pain reliever industry. Alternative solutions have been demanded by patients and healthcare professionals due to concerns over addiction, tolerance building, and other negative effects related to oral pain drugs, particularly opioids. Topical analgesics offer a focused method of relieving localized pain without the systemic side effects that are sometimes connected to oral drugs. The market for pain relievers currently has a large window of opportunity due to this shift in preferences.

Global topical pain relief market restraint:

Risk of overuse and dependence

The convenience of application of topical analgesics could pose limitations. Even though they are simple to use and provide focused relief, misuse may have unforeseen repercussions. For instance, over time, using substitutes containing anti-inflammatory medications may irritate the skin or maybe endanger renal function. Furthermore, certain components may develop an addiction when the body grows reliant on the drug to manage pain, creating a vicious cycle in which more and more of the substance is required to provide the same level of comfort. As patients deal with possible long-term negative effects, this might impede market expansion.

Global topical pain relief market opportunities:

Increasing technological advancements

The market will benefit from technological advancements with the introduction of smart irrigation devices. App connectivity enables individualized cleaning routines based on dentist recommendations or user preferences. Pressure sensors and automatic closing functions increase user safety and comfort. Moreover, features such as in-built active water jet technology it also gaining traction. For instance, in August 2020, Panasonic Holdings Corporation launched a new portable ultrasonic topical pain relief EW1511 with built-in active water jet technology, five pressure levels and a unique cordless design. It also features a flexible nozzle ultrasonic water jet with tiny bubbles that remove food particles and remove bacteria from periodontal pockets and floating plaque that can cause gum disease. With around 1,600 pulses per minute, it also gently stimulates the gums.

Growing focus on oral health awareness

Increasing oral health awareness and topical pain relief sales can be accomplished via collaborating with dentists. Manufacturers can leverage their reliable expertise to educate customers about the advantages of staying hydrated by collaborating with dental professionals and hygienists. This can be achieved via specific instructional materials provided in dental practices, in-office consultations, and cooperatively created marketing initiatives that highlight the ways in which irrigators supplement customary brushing and flossing to maintain gum health and oral hygiene. Patients become informed consumers who recognize the benefits of topical pain relief as a result of this strategic collaboration, which also increases trust and credibility.

Regional Analysis

Based on region, the global topical pain relief market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North america dominates the global market

North America is the most significant global market shareholder and is expected to expand substantially during the forecast period. North America leads the topical pain reliever market due to a perfect storm: high prevalence of chronic pain, strong healthcare systems that drive diagnosis and treatment with topical options, strong research and development by key major pharmaceutical players.

U.S. topical pain relief market. Chronic pain drives the U.S. topical pain relief market. Easy access to healthcare professionals and over-the-counter options, along with strong R&D by major pharma companies, solidify U.S. dominance.

Canada topical pain relief market. Canada’s well-developed healthcare system facilitates diagnosis and treatment with topical options and rising awareness of topical pain relief benefits and easy access to over-the-counter medications solidify Canada's market strength.

Thus, the factors above are estimated to boost the North America topical pain relief market growth.

Asia-Pacific region is a pivotal market for the arthroscopic shaver industry. Pain relief options are becoming more affordable, increasing accessibility for a wider Indian consumer base. Additionally, a preference for natural products is on the rise in India, and many topical pain relievers are formulated with natural ingredients like menthol and turmeric, further propelling topical pain relief market growth.

The China topical pain relief market. Rising disposable income fuels spending on healthcare products like topical pain relievers. Investments in domestic production further strengthens China's position in the Asia Pacific market.

The India topical pain relief market. Rising disposable income among a growing middle class, and a growing prevalence of dental problems caused by sugary diets and lifestyle choices are contributing to the country’s market growth.

These factors are estimated to drive the Asia Pacific topical pain relief market growth.

Segmental Analysis

The global market is bifurcated into drug class, formulation, type, and distribution channel.

Based on drug class, the market is segmented into opioids and non-opioids.

Non-opioids dominate the drug class segment. Since non-opioid medications are more widely available and often sold without a prescription, mild to moderate pain can be easily self-treated. In addition, they generally have a safer profile than opioids, mitigating concerns about addiction and broader systemic effects. Based on application, the market is segmented into home and dentistry.

Based on formulation, the market is segmented into creams and ointments, gels, sprays, patches, and others.

Creams and ointments dominate the formulation segment. Creams are adaptable, accommodating different kinds of pain and varying dosages of medicine. Additionally, they are might be slightly better at absorbing the ingredients, which could result in a greater soothing impact.

Based on type, the market is segmented into prescription based and over-the-counter (OTC).

Over-the-counter (OTC) dominate the type segment. Easy access makes it possible to quickly treat mild discomfort without consulting a doctor. Furthermore, they are better suited for a wider range of consumers because to their typically milder side effect profile as compared to prescription alternatives. OTC dominates the topical pain relief market due to its strong safety profile and convenient nature.

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Retail pharmacies dominate the distribution channel segment. This is because they are widely available and convenient to consumers seeking immediate relief. Online pharmacies, on the other hand, are expanding rapidly and might eventually challenge traditional retail's dominance with their convenient and possibly affordable prices.

Recent Developments

• In August 2023, Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced they have showcased new topical Tylenol Precise Pain-Relieving Cream, the first U.S. product launch from Kenvue since it became a publicly traded company during the PAINWeek Conference 2023 at The Cosmopolitan in Las Vegas, Nevada.
• In May 2023, The Consumer Health Division of Bayer had launched a business unit focused on developing new Precision Health products including cardiovascular and digestive health to pain management and immunity products and services across its range of everyday health categories. Bayer had prioritized developing products that enable people to take greater control of their own personal health through digital solutions that facilitate more informed choices based on personal insights and novel delivery mechanisms.
• In March 2021, Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the manufacturers of the Salonpas line of pain-relieving products, announced the availability of the Salonpas Arthritis Pain Relief Gel, which features the most prescribed topical pain medicine clinically proven to relieve arthritis pain in major joints.

Analyst’s Perspective:

According to analysts, the topical pain relief market is growing significantly over the forecast period. The two primary drivers of growth are: 1) rising consumer awareness of the need of maintaining good oral hygiene; and 2) expanding demand for easy-to-use at-home dental treatments. The Asia-Pacific area presents tremendous development potential due to its expanding population and rising disposable income, especially in the area of basic irrigation equipment. However, the deployment of advanced irrigation methods is anticipated to continue in North America, where dentistry is its established concentration. This demonstrates the market's capacity to cater to both experienced dental professionals seeking the newest advancements and budget-conscious new consumers.